Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1